Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid-β, tau, and the cholinergic system in Alzheimer’s disease: seeking direction in a tangle of clues
Alireza Majdi, Saeed Sadigh‐Eteghad, Sepideh Rahigh Aghsan, et al.
Reviews in the Neurosciences (2020) Vol. 31, Iss. 4, pp. 391-413
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Role of Cholinergic Signaling in Alzheimer’s Disease
Zhi-Ru Chen, Jiabao Huang, Shu‐Long Yang, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1816-1816
Open Access | Times Cited: 377
Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
Roberta Cascella, Cristina Cecchi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4914-4914
Open Access | Times Cited: 117
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Basal forebrain cholinergic signalling: development, connectivity and roles in cognition
Mala Ananth, Prithviraj Rajebhosale, Ronald Kim, et al.
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 4, pp. 233-251
Open Access | Times Cited: 57
Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease
Muna A. Adem, Boris Decourt, Marwan N. Sabbagh
Biomedicines (2024) Vol. 12, Iss. 1, pp. 99-99
Open Access | Times Cited: 15
Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis
Monika Sharma, Ankur Kumar Tanwar, Paresh Kumar Purohit, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 161, pp. 105685-105685
Closed Access | Times Cited: 11
Saffron (Crocus sativus L.) extract attenuates chronic scopolamine-induced cognitive impairment, amyloid beta, and neurofibrillary tangles accumulation in rats
Komal Patel, Abhay Dharamsi, Madhu Priya, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117898-117898
Closed Access | Times Cited: 8
The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses
Elana R. Lockshin, Nicole Calakos
Current Opinion in Neurobiology (2024) Vol. 87, pp. 102886-102886
Open Access | Times Cited: 8
Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review
Radhakrishna Reddi Sree, Manjunath Kalyan, Nikhilesh Anand, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 5148-5171
Open Access | Times Cited: 1
Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease
Xia Jiang, Ziwen Zhang, Jiawei Zuo, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113735-113735
Closed Access | Times Cited: 44
The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease
Mariana G. Fronza, Diego Alves, Domenico Praticò, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102033-102033
Closed Access | Times Cited: 21
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer’s-like Tauopathy Mouse Model
Maciej Zadrożny, Patrycja Drapich, Anna Gasiorowska-Bien, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 642-642
Open Access | Times Cited: 6
Role of Hypoxia Inducible Factor-1α in Alzheimer’s Disease
Yangyang Wang, Zhenting Huang, Minghao Yuan, et al.
Journal of Alzheimer s Disease (2021) Vol. 80, Iss. 3, pp. 949-961
Closed Access | Times Cited: 38
The role of the autonomic nervous system in cerebral blood flow regulation in dementia: A review
Lucy Beishon, Patrick S. Hosford, Dewaker Gurung, et al.
Autonomic Neuroscience (2022) Vol. 240, pp. 102985-102985
Open Access | Times Cited: 23
Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect
Inês Ferreira, Amélia P. Rauter, Narcisa M. Bandarra
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 662-662
Open Access | Times Cited: 23
A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives
Ai‐Hong Yang, Chang Liu, Hongwei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114216-114216
Closed Access | Times Cited: 22
Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design
Manish Tripathi, Bhagwati Bhardwaj, Digambar Kumar Waiker, et al.
Journal of Molecular Structure (2023) Vol. 1286, pp. 135517-135517
Closed Access | Times Cited: 14
Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer disease
Meng Zhang, Liyuan Liu, Yong Xu, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 7, pp. 2465-2476
Open Access | Times Cited: 13
Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia
Shereen M. Samir, Hend M Hassan, Rasha Elmowafy, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
Quality by design endorsed fabrication of xanthohumol loaded solid nanostructured lipid carrier based powder for effective treatment of Alzheimer's disease in rats
Nikhil Khandale, Devendra Birla, Md. Shahbaz Alam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106792-106792
Closed Access
Daily mindfulness practice with and without slow breathing has opposing effects on plasma amyloid beta levels
Kaoru Nashiro, B. Rael Cahn, Paul D. Choi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Virtual screening and molecular dynamics of anti-Alzheimer compounds from Cardiospermum halicacabum via GC-MS
Selvan Kaviyarasu, Nallamuthu Padmanaban, Sulekha Khute, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
The Na+/Ca2+exchanger in Alzheimer’s disease
Anna Pannaccione, Ilaria Piccialli, Agnese Secondo, et al.
Cell Calcium (2020) Vol. 87, pp. 102190-102190
Closed Access | Times Cited: 37
3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink
Claire Benwood, Jonathan Walters-Shumka, Kali Scheck, et al.
Bioelectronic Medicine (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease
Beatriz Piniella-Matamoros, Javier Marín‐Prida, Giselle Pentón‐Rol
Journal of Biosciences (2021) Vol. 46, Iss. 2
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top